ClinConnect ClinConnect Logo
Search / Trial NCT03120312

Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement

Launched by SECOND HOSPITAL OF SHANXI MEDICAL UNIVERSITY · Apr 15, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Outcome

ClinConnect Summary

This clinical trial is looking at the experiences and outcomes of elderly patients who have undergone total hip replacement surgery over the past five years. The goal is to understand how these surgeries affect older patients both in the short term (right after surgery) and the long term (years later). The researchers want to gather information that can help improve care for future patients needing this type of surgery.

To be eligible for the trial, participants should be elderly patients who are planning to have this surgery and are generally healthy, with no severe health problems or past joint replacements. The study is currently looking for participants and is open to men and women within a specific age range. Those who join can expect to contribute valuable information that may help doctors better understand the effects of hip replacement surgery on older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. ASA Ⅱ-Ⅲ,elective operation patients,
  • 2. NO other severe complication history
  • Exclusion Criteria:
  • 1. Having severe comorbidity
  • 2. not for the first time of joint replacement
  • 3. Suffered from neurologic disorder or impaired mental state

About Second Hospital Of Shanxi Medical University

The Second Hospital of Shanxi Medical University is a prominent clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. As a key affiliate of Shanxi Medical University, the hospital combines cutting-edge research with clinical expertise, facilitating a multidisciplinary approach to address various health challenges. Committed to ethical research practices and patient safety, the Second Hospital actively collaborates with healthcare professionals and academic partners to conduct rigorous studies that contribute to evidence-based medicine and enhance treatment options for diverse patient populations.

Locations

Taiyuan, Shanxi, China

Patients applied

0 patients applied

Trial Officials

Zheng Guo

Study Chair

Second Hospital of Shanxi Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials